← Evidence map

ArticleAnnals of surgical oncology2025

Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.

Neha Shafique et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40940600